Biological Information

Background Information:

Evaluation of two compounds in any BioMAP system, individually and in combination. The StroHT29 system is comprised of dermal fibroblasts, the HT-29 colorectal adenocarcinoma cell line, and peripheral blood mononuclear cells. This stromal tumor microenvironment (TME) model is stimulated via the T cell receptor for 48-hrs to recapitulate the activation of tumor infiltrating immune cells in the context of an immunosuppressive cancer cell line and normal host stromal tissue. These conditions model the host stromal-immune-tumor microenvironment by capturing the complex interactions between tumor cells, the host stromal network, and infiltrating immune cells recruited into the tumor mass. Biomarker readouts capture impacts on translationally relevant immune, matrix remodeling, and inflammation-related intratumoral responses.

Organism:

Human

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Testing Information

Test Concentration / Dose:

Two test agents profiled alone at four concentrations, and in combination in a four-by-four matrix, in triplicate.

Test Sample Requirements:

For Small Molecules: 350uL of a 1000X stock based on the top concentration being tested & standard 3-fold dilutions per system and per Combo. For Biologics: 3.5mL of a 100X stock in PBS or water, based on the top concentration being tested & standard 3-fold dilutions per system and per Combo

Turnaround Time

Standard:

40 Business Days

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

BioMAP

Testing Location:

USA - St Charles, MO

RELATED SOLUTIONS

Item: 89-0003-0045
Item: 89-0015-0047
Item: 89-0035-0045
Item: 89-0044-0901
Item: HT2MP03
Item: HT2MP05
Item: HT2MP10
Item: HT2SP03
Item: HT2SP05
Item: HT2SP10
Item: HT2SP3D
Item: PSOP0001
Item: PSOP0002
Item: PSOP0003
Item: PSOP0010
Item: PSOP0011
Item: PSOP0012
Item: PSOP0013
Item: PSOP0014
Item: PSOP0015